Results 201 to 210 of about 19,107 (290)
Inclisiran: A Systematic Review Exploring the Revolutionary Approach of Twice-Yearly Dosing Regimen in the Treatment of Hypercholesterolemia. [PDF]
Singareddy S +6 more
europepmc +1 more source
Abstract Objective Hormonal contraception, especially combined oral contraceptives, is associated with an increase in cardiovascular risk. Thus, we aimed to analyze the use of hormonal contraceptive methods in the state of Rio de Janeiro (Brazil), with a focus on determining whether contraceptive use follows the cardiovascular profile of women ...
Isabela Pereira Fonseca Brusth +2 more
wiley +1 more source
New-Onset Autoantibody-Negative Diabetes With DKA Following Lorlatinib Therapy for ALK-Positive NSCLC. [PDF]
Dharia A, Pleet A, West B, Jaiswal G.
europepmc +1 more source
Plethora of adverse drug reactions in geriatric population receiving statin therapy for dyslipidaemia. [PDF]
Padhye MR, Yadav NS.
europepmc +1 more source
Beneficial effects of crude extract ofEupatorium lindleyanumDC. in hyperlipidemia and atherosclerosis [PDF]
Xing Zhou +6 more
openalex +1 more source
Abstract Background The triglyceride‐glucose body mass index (TyG‐BMI) is a novel indicator combining an insulin resistance proxy (TyG index) with adiposity. It remains unclear how TyG‐BMI relates to long‐term mortality risk in postmenopausal women, a group prone to metabolic changes after menopause.
Xiliang Wang +3 more
wiley +1 more source
Temporal patterns of triglyceride testing and test results among adults with severe or extreme hypertriglyceridemia in US clinical practice. [PDF]
Sikora Kessler A +7 more
europepmc +1 more source
Metabolomic & lipidomic analysis reveals metabolic overlap between CAD & T2DM, highlighting 7 key metabolites as potential biomarkers. A predictive model based on these achieves high accuracy, potentially advancing precision medicine & metabolic insights.
Zhihua Wang +9 more
wiley +1 more source
Research advances in current drugs targeting hyperlipidemia (Review). [PDF]
Zhao H, Wang Y, Li Y, Cheng R, Chen W.
europepmc +1 more source

